Table 1

General and disease characteristics as well as endothelial function scores for patients in the cross-sectional study

RA patients

Number


General characteristics

Sex female n (%)

72 (73)

99

Disease characteristics

RF positive n (%)

70 (78)

90

Disease duration (years)

11 ± 10

74

ESR (mm/hr)

17.0 (8.8-28.3)

90

CRP (mg/L)

5.0 (2.9-13.50)

93

DAS28

3.6 ± 1.3

93

HAQ

1.7 ± .87

95

RA medications

Methotrexate n (%)

60 (60)

99

Prednisolone n (%)

22 (22)

99

NSAIDS n (%)

18 (18)

99

Cyclooxygenase II inhibitors n (%)

11 (11)

99

Anti-TNF-α therapy n (%)

11 (11)

99

CVD medications

Antihypertensive n (%)

25 (25)

99

Antihypercholesterolemic n (%)

12 (12)

99

Beta-blocker n (%)

7 (7)

99

Calcium channel blocker n (%)

5 (5)

99

Microvascular function

Endothelium-dependent (ACh%)

236 (152-407)

94

Endothelium-independent (SNP%)

261 (181-384)

94

Macrovascular function

Endothelium-dependent (FMD%)

9.5 (4.8-13.5)

96

Endothelium-independent (GTN%)

24.0 (16.3-30.4)

93


Results are expressed as number (percentage), mean ± SD, or median (25th to 75th) percentile, as appropriate. Ach, acetylcholine; CRP, C-reactive protein; CVD, cardiovascular disease; DAS28, disease activity score in 28 joints; ESR, erythrocyte sedimentation rate; FMD, flow-mediated dilatation; GTN, glyceryl trinitrate; HAQ, Health Assessment Questionnaire, NSAID, nonsteroidal antiinflammatory drug; RA, rheumatoid arthritis; RF, rheumatoid factor; TNF, tumor necrosis factor; SNP, sodium nitroprusside.

Sandoo et al. Arthritis Research & Therapy 2012 14:R117   doi:10.1186/ar3847

Open Data